Stocks and Investing Stocks and Investing
Tue, January 31, 2023

Kevin Caliendo Maintained (CAH) at Strong Buy with Increased Target to $91 on, Jan 31st, 2023


Published on 2024-10-28 01:13:25 - WOPRAI, Kevin Caliendo
  Print publication without navigation


Kevin Caliendo of UBS, Maintained "Cardinal Health, Inc." (CAH) at Strong Buy with Increased Target from $78 to $91 on, Jan 31st, 2023.

Kevin has made no other calls on CAH in the last 4 months.



There are 5 other peers that have a rating on CAH. Out of the 5 peers that are also analyzing CAH, 4 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • A.J. Rice of "Credit Suisse" Maintained at Hold with Increased Target to $79 on, Tuesday, November 22nd, 2022
  • Ann Hynes of "Mizuho" Maintained at Hold with Increased Target to $74 on, Monday, November 14th, 2022
  • Eric Coldwell of "Baird" Maintained at Hold with Increased Target to $82 on, Monday, November 7th, 2022
  • Michael Cherny of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $80 on, Friday, November 4th, 2022


This is the rating of the analyst that currently disagrees with Kevin


  • Erin Wright of "Morgan Stanley" Maintained at Buy with Increased Target to $86 on, Friday, January 6th, 2023
Contributing Sources